Issued by: XRP Healthcare
XRP Healthcare, a pioneering force in healthcare innovation, has officially acquired Pharma Ville, a retail and wholesale pharmacy chain in Uganda.
This strategic acquisition marks XRP Healthcare’s entry into Africa’s rapidly evolving healthcare sector and lays the foundation for a scalable, technology-driven pharmaceutical distribution across the continent.
With two retail pharmacies and five wholesale distribution centres strategically located across Uganda, Pharma Ville’s established infrastructure improves access to medicines nationwide. The acquisition strengthens XRP Healthcare’s ability to streamline pharmaceutical supply chains and expand its footprint in the African healthcare market.
Shonubi Musoke & Co. Advocates, one of Uganda’s leading law firms, advised XRP Healthcare on the transaction to ensure a seamless legal and regulatory transition.
Pharma Ville plays a pivotal role in Uganda’s healthcare sector, working closely with the National Medical Stores and Joint Medical Stores to ensure a steady and reliable supply of essential medicines.
The acquisition includes 60 registered pharmaceutical products, 18 products ready for immediate commercialisation and a further 70 products in the pipeline awaiting regulatory approval.
In addition, Pharma Ville has distribution agreements with eight global pharmaceutical suppliers, reinforcing its strong supply chain network;
- Toros Group (Switzerland) – Orthopaedic supplies
- Ascensia Switzerland (Germany) – Diabetes care solutions
- Incepta Pharmaceuticals Ltd (Bangladesh) – Human pharmaceuticals
- Amanta Health Care Limited (India) – Intravenous solutions
- Forans Latvia (Latvia) – Diabetic care products
- Mediteks (Turkey) – Surgical devices
- Naari Pharma Pvt Limited (India) – Human pharmaceuticals
- Universal Corporation Limited (Kenya) – Human pharmaceuticals.
Richard Kitonsa, founder and chief executive of Pharma Ville, emphasised the transformative impact of this acquisition:
“Joining XRP Healthcare is transformative. We will now be able to rapidly scale our operations, introduce innovative technologies, and better serve Uganda’s healthcare needs.”
Whitney Lynn, Chairman of XRP Healthcare, underlined the company’s mission:
“Our goal is simple — to make essential medicines more accessible and affordable. This acquisition is an important step towards achieving that.”
Kain Roomes, CEO of XRP Healthcare, highlighted the opportunity in Uganda’s healthcare sector:
“Uganda’s fragmented pharmaceutical landscape has immense potential. By integrating Pharma Ville, we can make an immediate impact — improving access to essential medicines and optimising healthcare delivery.”
Laban Roomes, COO of XRP Healthcare, highlighted the groundwork laid for expansion:
“We have spent a significant amount of time in Uganda developing the legal and operational frameworks necessary to rapidly scale this business. Our efforts will drive long-term improvements in healthcare accessibility.”
Pharma Ville will undergo immediate operational improvements, including:
- Advanced inventory management to optimise supply chains
- Upgraded licensing to expand product offerings
- Enhanced distribution channels for greater reach
- Integration of digital payments for seamless transactions
- New CRM systems to improve customer retention.
Pharma Ville will be rebranded as XRP Healthcare by the fourth quarter of this year, in line with the company’s vision for innovation and healthcare excellence.
The XRPH AI app, a multilingual healthcare assistant, is already live and integrated into Pharma Ville’s digital platform (www.pharmaville.ai). The AI-powered tool provides medical advice in Luganda, Swahili, Kinyarwanda, French and English.
In a forthcoming update, users will be able to upload images of medical conditions for AI-assisted preliminary assessments, with direct referrals to healthcare professionals for critical cases.
Peter Waiswa, a strategic advisor to UNICEF, the Bill & Melinda Gates Foundation and now XRP Healthcare, noted the significance of the acquisition, saying it would “strengthen Uganda’s healthcare sector, drive economic growth and introduce essential technologies to the [pharmaceutical] sector”, as well as improve access to healthcare in the country.
With the African healthcare market projected to reach $259 billion by 2030, and the digital health segment – which includes AI-driven solutions – expected to grow to $16.6 billion, XRP Healthcare is strategically positioned to capitalise on these transformative opportunities.
XRP Healthcare holds registered trademarks in Uganda, the United Arab Emirates and the United Kingdom, with global registrations in progress, reinforcing its commitment to innovation and brand excellence.
About XRP Healthcare
XRP Healthcare is a pioneering healthcare solutions provider, using AI and strategic acquisitions to improve healthcare accessibility and efficiency. By integrating digital innovation with traditional pharmaceutical distribution, XRP Healthcare is at the forefront of revolutionising healthcare delivery in emerging markets.
